Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C40H36N8O5.CH4O3S |
| Molecular Weight | 804.87 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(O)(=O)=O.OC1=CC=C(C[C@@H]2N3[C@H](CN(CC4=CC=CC5=NC=CC=C45)C2=O)N(N(CC6=CC(=NO6)C7=NC=CC=C7)CC3=O)C(=O)NCC8=CC=CC=C8)C=C1
InChI
InChIKey=HRTDXYPAIIXIKY-GVGVJZOBSA-N
InChI=1S/C40H36N8O5.CH4O3S/c49-30-16-14-27(15-17-30)20-36-39(51)45(23-29-10-6-13-33-32(29)11-7-19-41-33)25-37-47(36)38(50)26-46(48(37)40(52)43-22-28-8-2-1-3-9-28)24-31-21-35(44-53-31)34-12-4-5-18-42-34;1-5(2,3)4/h1-19,21,36-37,49H,20,22-26H2,(H,43,52);1H3,(H,2,3,4)/t36-,37-;/m0./s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
884022
Created by
admin on Wed Apr 02 16:43:21 GMT 2025 , Edited by admin on Wed Apr 02 16:43:21 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
BC3NAR7TV9
Created by
admin on Wed Apr 02 16:43:21 GMT 2025 , Edited by admin on Wed Apr 02 16:43:21 GMT 2025
|
PRIMARY | |||
|
2710292-19-4
Created by
admin on Wed Apr 02 16:43:21 GMT 2025 , Edited by admin on Wed Apr 02 16:43:21 GMT 2025
|
PRIMARY | |||
|
160760377
Created by
admin on Wed Apr 02 16:43:21 GMT 2025 , Edited by admin on Wed Apr 02 16:43:21 GMT 2025
|
PRIMARY |
![Structure of (6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-4,7-dioxo-2-((3-(pyridin-2-yl)isoxazol-5-yl)methyl)-8-(quinolin-5-ylmethyl)hexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide](/img/189bdc67-6df3-402d-8520-2c80005047f8.svg "Structure of (6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-4,7-dioxo-2-((3-(pyridin-2-yl)isoxazol-5-yl)methyl)-8-(quinolin-5-ylmethyl)hexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide")
![Structure of (6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-4,7-dioxo-2-((3-(pyridin-2-yl)isoxazol-5-yl)methyl)-8-(quinolin-5-ylmethyl)hexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide methane sulfonic acid](/img/c75168f7-1606-430f-b331-3483886c2d38.svg "Structure of (6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-4,7-dioxo-2-((3-(pyridin-2-yl)isoxazol-5-yl)methyl)-8-(quinolin-5-ylmethyl)hexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide methane sulfonic acid")